naltrexone has been researched along with Alcoholic Cirrhosis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (75.00) | 2.80 |
Authors | Studies |
---|---|
Falker, C; Garcia-Tsao, G; Kaplan, DE; Mahmud, N; Rabiee, A; Taddei, T | 1 |
Avanceña, ALV; Hutton, DW; Mellinger, JL; Miller, N; Uttal, SE | 1 |
Tamaki, K | 1 |
Pár, A | 1 |
1 review(s) available for naltrexone and Alcoholic Cirrhosis
Article | Year |
---|---|
[Treatment of alcoholic liver diseases. Abstinence, nutritional support, drug therapy, liver transplantation].
Topics: Alcohol Deterrents; Antioxidants; Drug Combinations; Fatty Liver, Alcoholic; Hormones; Humans; Liver; Liver Cirrhosis, Alcoholic; Liver Diseases, Alcoholic; Liver Transplantation; Naltrexone; Narcotic Antagonists; Nutritional Support; Protective Agents; Pyridoxine; Pyrrolidonecarboxylic Acid; Silymarin | 2000 |
3 other study(ies) available for naltrexone and Alcoholic Cirrhosis
Article | Year |
---|---|
Medications for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated cirrhosis.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Naltrexone; Retrospective Studies | 2023 |
Cost-effectiveness of alcohol use treatments in patients with alcohol-related cirrhosis.
Topics: Acamprosate; Aged; Alcohol Deterrents; Alcoholism; Cohort Studies; Cost-Benefit Analysis; Female; Health Care Costs; Humans; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Naltrexone; Quality-Adjusted Life Years; Treatment Outcome | 2021 |
[Four cases of alcoholic liver cirrhosis in alcohol-dependent patients treated with nalmefene].
Topics: Alcohol Drinking; Alcoholism; Europe; Humans; Japan; Liver Cirrhosis, Alcoholic; Naltrexone | 2021 |